Install
Pharma: J&J, Merck and Bristol Myers
Pharma: J&J, Merck and Bristol Myers: hiring, expansion, leadership and results.
- 6 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Pharma: J&J, Merck and Bristol Myers
Legend Biotech taps Novartis veteran Zhang as CEO
3+ hour, 57+ min ago (58+ words) Legend Biotech on Tuesday appointed longtime Novartis executive Ingrid Zhang as its CEO, effective immediately, banking on an industry veteran to steer its expansion beyond blockbuster cancer... Biotechnology & Medical Research Legend Biotech taps Novartis veteran Zhang as CEO Published on…...
AstraZeneca strikes $40 million AI drug discovery deal with insitro
8+ hour, 32+ min ago (13+ words) Central Oregon Daily...
Bristol Myers Squibb Company $BMY Position Reduced by Fort Washington Investment Advisors Inc. OH
8+ hour, 2+ min ago (1161+ words) MarketBeat Bristol Myers Squibb Company $BMY Position Reduced by Fort Washington Investment Advisors Inc. OH - Fort Washington Investment Advisors cut its Bristol Myers Squibb position by 25.5% in the third quarter, selling 588,083 shares and retaining 1.72 million shares valued at approximately $107.1 million....
$237.7M Loan Secured for Novartis-Anchored Pathway Triangle Biomanufacturing Campus in Morrisville
22+ hour, 35+ min ago (391+ words) BioBuzz $237.7M Loan Secured for Novartis-Anchored Pathway Triangle Biomanufacturing Campus in Morrisville JLL Capital Markets announced on October 12, 2026 that it has arranged $237.7 million in financing for Phase I of Pathway Triangle, a cGMP and advanced manufacturing campus in Morrisville, North Carolina,…...
Johnson & Johnson Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Johnson & Johnson (JNJ)
1+ day, 5+ min ago (431+ words) Oct 14, 2026, 15:02 ET China pricing and European budget cuts were cited among the pressures behind a MedTech consensus miss that sent Johnson & Johnson shares lower. JNJ investors with losses can request a review. Reuters, Barron's, The Wall Street Journal, and CNBC…...
JNJ Maintains Rating by Leerink Partners -- Price Target Lowered to $272
21+ hour, 10+ min ago (260+ words) On October 14, 2026, analyst David Risinger from Leerink Partners maintained the 'Outperform' rating for Johnson & Johnson JNJ. However, he lowered the price target from $276.00 to $272.00, reflecting a decrease of 1.45%. The GF Score™ is a comprehensive measure that evaluates a company's financial…...
Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?
1+ day, 5+ hour ago (468+ words) Merck's MRK revenues are primarily derived from the oncology portfolio, led by its blockbuster PD-L1 inhibitor, Keytruda. The drug accounts for more than 55% of the company's pharmaceutical sales. Keytruda generated $16.40 billion in sales in the first six months of 2026, increasing…...
HALO Stock Rallies As Patent Wins Boost Settlement Hopes
1+ day, 2+ hour ago (212+ words) Halozyme Therapeutics Inc. stocks have been trading up by 7.43 percent following upbeat sentiment on its oncology pipeline progress. Halozyme Therapeutics Inc. has been trading like a steady climber. Over the last few weeks, HALO has held above $106 and just closed…...
Medicine sold on Amazon has been recalled
1+ day, 7+ hour ago (49+ words) WFAA Medicine sold on Amazon has been recalled To stream WFAA on your phone, you need the WFAA app. Download the WFAA app Next up in 5 Example video title will go here for this video Before You Leave, Check This…...
Bayer to build $2.2B plant in New Albany
2+ day, 21+ hour ago (143+ words) Ohio has landed a $2.2 billion plant that will be built in New Albany by pharmaceutical giant Bayer. Gov. Mike DeWine said the project will create 600 jobs. “This project firmly solidifies Ohio’s place among global biomanufacturing leaders as a destination for…...